459 related articles for article (PubMed ID: 22876288)
41. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
Wang J; Wang S; Zhou J; Qian Q
Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
Li Y; Wang YW; Chen X; Ma RR; Guo XY; Liu HT; Jiang SJ; Wei JM; Gao P
Clin Breast Cancer; 2020 Apr; 20(2):e113-e126. PubMed ID: 31899158
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression.
Peng Y; Liu YM; Li LC; Wang LL; Wu XL
PLoS One; 2014; 9(4):e94422. PubMed ID: 24736504
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer.
Maimaitiming A; Wusiman A; Aimudula A; Kuerban X; Su P
Oncol Res; 2020 Feb; 28(1):13-19. PubMed ID: 30982494
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
49. RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells.
Liu Z; Chen L; Zhang X; Xu X; Xing H; Zhang Y; Li W; Yu H; Zeng J; Jia J
J Cell Mol Med; 2014 Apr; 18(4):610-23. PubMed ID: 24447545
[TBL] [Abstract][Full Text] [Related]
50. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
51. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
[TBL] [Abstract][Full Text] [Related]
52. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
54. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
55. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
56. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
57. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
58. miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway.
Cheng Z; Liu F; Zhang H; Li X; Li Y; Li J; Liu F; Cao Y; Cao L; Li F
Oncotarget; 2017 May; 8(19):31153-31168. PubMed ID: 28415713
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.
Fite K; Gomez-Cambronero J
J Biol Chem; 2016 Jan; 291(2):719-30. PubMed ID: 26567912
[TBL] [Abstract][Full Text] [Related]
60. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]